Literature DB >> 26525196

Urinary markers in the early stage of nephropathy in patients with childhood-onset type 1 diabetes.

Jin-Soon Suh1, Shin-Hee Kim1, Kyoung Soon Cho1, In-Ah Jung1, Won Kyoung Cho1, Yeon Jin Jeon1, Min Ho Jung2, Byoung Kyu Suh1.   

Abstract

BACKGROUND: The aim of this study was to evaluate the association of a urinary tubular marker, liver-type fatty acid binding protein (L-FABP) and an inflammatory marker, serum/urinary YKL-40, with albuminuria in patients with childhood-onset type 1 diabetes (T1D).
METHODS: Twenty-nine patients with childhood-onset T1D and 32 controls were enrolled. Serum and urinary concentrations of YKL-40 and urinary concentrations of L-FABP were measured.
RESULTS: The serum levels of YKL-40 were not significantly different between the control group and the patient groups. However, the levels of urinary YKL-40/creatinine (Cr) were higher in the patients, even those with normoalbuminuria than in the controls (p < 0.001). The levels of urinary L-FABP/Cr were not different between the control group and the patient groups. However, the level of urinary L-FABP/Cr in the microalbuminuria group was higher than that in the normoalbuminuria group (p = 0.03). There were no associations between the levels of urinary albumin-to-creatinine ratio and urinary L-FABP/Cr or YKL-40/Cr. However, the urinary L-FABP/Cr level was significantly correlated with the hemoglobin A1C level (p = 0.005) and the urinary YKL-40/Cr level (p = 0.043).
CONCLUSIONS: Urinary L-FABP/Cr and YKL-40/Cr may reflect renal injury in early stages of nephropathy in patients with childhood-onset T1D, even in the normoalbuminuric state.

Entities:  

Keywords:  Albuminuria; Biomarkers; Children; Diabetic nephropathy; Liver-type fatty acid binding protein; YKL-40

Mesh:

Substances:

Year:  2015        PMID: 26525196     DOI: 10.1007/s00467-015-3253-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  47 in total

1.  Clinical implication of plasma and urine YKL-40, as a proinflammatory biomarker, on early stage of nephropathy in type 2 diabetic patients.

Authors:  Jun Ho Lee; Sang Soo Kim; In Joo Kim; Sang Heon Song; Yong Ki Kim; Ju In Kim; Yun Kyung Jeon; Bo Hyun Kim; Ihm Soo Kwak
Journal:  J Diabetes Complications       Date:  2012-06-15       Impact factor: 2.852

2.  Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.

Authors:  Vishal S Vaidya; Monika A Niewczas; Linda H Ficociello; Amanda C Johnson; Fitz B Collings; James H Warram; Andrzej S Krolewski; Joseph V Bonventre
Journal:  Kidney Int       Date:  2010-10-27       Impact factor: 10.612

3.  Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy.

Authors:  Tsukasa Nakamura; Takeshi Sugaya; Yasuhiro Kawagoe; Yoshihiko Ueda; Shiwori Osada; Hikaru Koide
Journal:  Diabetes Care       Date:  2005-11       Impact factor: 19.112

Review 4.  Kidney function in early diabetes: the tubular hypothesis of glomerular filtration.

Authors:  Scott C Thomson; Volker Vallon; Roland C Blantz
Journal:  Am J Physiol Renal Physiol       Date:  2004-01

5.  Kidney function after improved metabolic control in newly diagnosed diabetes and in diabetic patients with nephropathy.

Authors:  A Ciavarella; M Flammini; S Stefoni; L C Borgnino; G Forlani; L Bacci; P Vannini
Journal:  Diabetes Care       Date:  1982 Nov-Dec       Impact factor: 19.112

6.  Renal L-type fatty acid--binding protein in acute ischemic injury.

Authors:  Tokunori Yamamoto; Eisei Noiri; Yoshinari Ono; Kent Doi; Kousuke Negishi; Atsuko Kamijo; Kenjiro Kimura; Toshiro Fujita; Tsuneo Kinukawa; Hideki Taniguchi; Kazuo Nakamura; Momokazu Goto; Naoshi Shinozaki; Shinichi Ohshima; Takeshi Sugaya
Journal:  J Am Soc Nephrol       Date:  2007-10-17       Impact factor: 10.121

7.  Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage.

Authors:  Takeshi Yokoyama; Atsuko Kamijo-Ikemori; Takeshi Sugaya; Seiko Hoshino; Takashi Yasuda; Kenjiro Kimura
Journal:  Am J Pathol       Date:  2009-05-12       Impact factor: 4.307

8.  Urinary biomarkers and acute kidney injury in children: the long road to clinical application.

Authors:  Helmut Schiffl; Susanne M Lang
Journal:  Pediatr Nephrol       Date:  2013-03-19       Impact factor: 3.714

9.  Tubular dysfunction in type I diabetes mellitus.

Authors:  M Miltényi; A Körner; T Tulassay; A Szabó
Journal:  Arch Dis Child       Date:  1985-10       Impact factor: 3.791

10.  Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria.

Authors:  Andrzej S Krolewski; Monika A Niewczas; Jan Skupien; Tomhito Gohda; Adam Smiles; Jon H Eckfeldt; Alessandro Doria; James H Warram
Journal:  Diabetes Care       Date:  2013-08-12       Impact factor: 19.112

View more
  4 in total

1.  Urinary l-type fatty acid-binding protein is a predictor of early renal function after partial nephrectomy.

Authors:  Masaaki Yanishi; Hidefumi Kinoshita; Takao Mishima; Hisanori Taniguchi; Kenji Yoshida; Yoshihiro Komai; Kaneki Yasuda; Masato Watanabe; Motohiko Sugi; Tadashi Matsuda
Journal:  Ren Fail       Date:  2016-10-21       Impact factor: 2.606

2.  Evaluation of Chitotriosidase and Neopterin as Biomarkers of Microvascular Complications in Patients with Type 1 Diabetes Mellitus.

Authors:  Ancuța Cutaș; Cristina Drugan; Gabriela Roman; Adriana Rusu; Cristina Sorina Cătană; Andrei Achimaș-Cadariu; Tudor Drugan
Journal:  Diagnostics (Basel)       Date:  2021-02-08

3.  Performance of urinary liver-type fatty acid-binding protein in diabetic nephropathy: A meta-analysis.

Authors:  Li Zhang; Shuai Xue; Meiyan Wu; Dan Dong
Journal:  Front Med (Lausanne)       Date:  2022-09-02

4.  Urinary YKL-40 as a Candidate Biomarker for Febrile Urinary Tract Infection in Young Children.

Authors:  Hyun Hee Kim; Mi Hae Chung; Joong Hyun Bin; Kyoung Soon Cho; Juyoung Lee; Jin Soon Suh
Journal:  Ann Lab Med       Date:  2018-01       Impact factor: 3.464

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.